Be a part of 7^th International Conference on Digestive and Gastrointestional Diseases

The 7th International Conference on Digestive and Gastrointestinal Diseases aims to bridge the gap between clinical research and therapeutic advancements in gut health. With the theme “Advancing GI Health for a Better Tomorrow” this forum promotes global collaboration, cutting-edge insights, and novel treatment approaches in gastroenterology, hepatology, and digestive science.

Why Attend?

• Stay updated on the latest research in gastrointestinal diagnostics and therapies
• Present your work, gain global recognition, and expand professional networks
• Learn from renowned experts and collaborate on new projects

Who Can Attend?

• Gastroenterologists & Hepatologists
• Digestive Disease Specialists & GI Surgeons
• Researchers, Scientists & Medical Students
• Healthcare Professionals & Nutrition Experts
• Pharmaceutical & Biotech Representatives

This event is a must-attend for anyone committed to improving digestive health worldwide.

Track 01: Advances in Gastrointestinal Endoscopy

Explore the latest imaging and diagnostic tools reshaping GI endoscopy, including AI-powered detection and minimally invasive procedures.

• AI in GI endoscopy
• Capsule endoscopy
• Endoscopic ultrasound (EUS)
• Therapeutic endoscopy

Track 02: Gut Microbiome and Human Health

Delve into the role of gut flora in digestive and metabolic health, disease prevention, and personalized treatments.

• Microbiome-targeted therapies
• Gut-brain axis
• Prebiotics and probiotics
• Dysbiosis and chronic inflammation

Track 03: Irritable Bowel Syndrome (IBS) and Functional GI Disorders

Understand the diagnostic approaches, clinical trials, and therapeutic innovations in managing functional bowel disorders.

• IBS-D, IBS-C, and mixed types
• Diet-based interventions (Low FODMAP)
• Brain-gut interaction
• Stress and GI disorders

Track 04: Inflammatory Bowel Diseases (IBD): Crohn’s & Ulcerative Colitis

Highlighting biologics, immunotherapies, and lifestyle strategies for long-term IBD management.

• Biologic response modifiers
• IBD in pediatrics
• Personalized IBD therapy
• Extraintestinal manifestations

Track 05: Liver Disorders and Hepatology

Current trends in hepatology including NASH, cirrhosis, viral hepatitis, and liver transplant advancements.

• Hepatitis A–E
• Non-alcoholic fatty liver disease (NAFLD)
• Liver fibrosis diagnostics
• Liver transplantation & immunology

Track 06: GI Oncology: Early Detection and Therapies

Focused on cancer screening, molecular diagnostics, and breakthrough therapies in gastrointestinal cancers.

• Colorectal and pancreatic cancers
• Esophageal and gastric cancer
• Immunotherapy in GI oncology
• Biomarkers and precision oncology

Track 07: Pediatric Gastroenterology

Explore gastrointestinal, liver, and nutrition disorders in infants and children, from diagnosis to long-term care.

• Pediatric IBD
• Gastroesophageal reflux disease (GERD)
• Neonatal jaundice
• Pediatric nutrition and malabsorption

Track 08: Gastrointestinal Surgery and Innovations

Advanced surgical approaches for treating GI diseases, including minimally invasive and robotic-assisted techniques.

• Laparoscopic GI surgery
• GI oncology surgery
• Postoperative care and complications
• Robotic-assisted digestive surgery

Track 09: Nutrition and Digestive Health

The science behind gut-friendly diets, functional foods, and their impact on digestive wellness.

• Dietary fiber and bowel health
• Role of polyphenols and fermented foods
• Nutrition in IBS/IBD
• Clinical dietetics in GI disease

Track 10: Gastrointestinal Pharmacology

Drug discovery and therapeutic agents for GI disorders with emphasis on efficacy and safety.

• Proton pump inhibitors
• Laxatives and motility drugs
• Targeted drug delivery
• Clinical trials and regulatory pathways

Track 11: GI Motility and Neurogastroenterology

Understand neural regulation and motility disorders affecting the digestive tract.

• Gastroparesis
• Hirschsprung’s disease
• Functional dyspepsia
• Neurotransmitters in gut function

Track 12: Digestive Infections and Gut Immunology

Insights into gut immunity, gut-barrier functions, and the management of GI infections.

• Gut mucosal immunology
• Clostridium difficile infection
• Intestinal tuberculosis
• Autoimmune GI disorders

Track 13: GERD and Esophageal Disorders

Study mechanisms, diagnostics, and the treatment spectrum of GERD and esophageal dysfunctions.

• Barrett’s esophagus
• Endoscopic therapies for GERD
• Dysphagia and achalasia
• Reflux-induced respiratory symptoms

Track 14: Advancements in Digestive Disease Diagnostics

Cutting-edge tools and methodologies revolutionizing the early diagnosis of digestive disorders.

• Breath tests and fecal biomarkers
• Radiologic imaging (CT/MRI)
• Endomicroscopy
• Genetic testing in GI diseases

Track 15: Young Researchers Forum in Gastroenterology

A platform to empower early-career scientists with mentoring, networking, and presentation opportunities.

• Oral and poster sessions
• Clinical case presentations
• Young Investigator Awards
• Research methodology workshops

Participation Benefits – Why Join DGDC-2025?

Participating in the 7th International Conference on Digestive and Gastrointestinal Diseases (DGDC-2025) offers unparalleled advantages for professionals in gastroenterology, digestive health research, hepatology, and related fields. Whether you're attending in person or virtually, this international digestive health conference provides the perfect platform to share knowledge, build networks, and elevate your professional profile.

Key Benefits for All Participants:

• Attend keynote sessions led by internationally renowned digestive health experts and gastroenterology researchers.
• Access all scientific sessions, panel discussions, and networking opportunities.
• Gain international recognition for your research contributions and professional achievements.
• Publish abstracts in high-impact international journals with unique DOIs.
• Enjoy publication discounts in open-access journals within the field of digestive health and gastroenterology.
• Receive exclusive conference handbooks, event kits, and printed materials.
• Network with global leaders in gastroenterology, hepatology, nutrition, and public health.
• Learn from groundbreaking studies, clinical advancements, and case discussions.
• Obtain certified participation for oral and poster abstracts.
• Create valuable global collaborations for future research, projects, and academic growth.

Participation Categories – Find Your Role at DGDC-2025

DGDC-2025 welcomes a wide range of participation options tailored to suit academics, clinicians, researchers, organizations, and companies involved in digestive health science and healthcare innovation:

• Keynote Speaker: Present a 45–50-minute keynote on cutting-edge digestive health topics as a thought leader and influential voice in the field.
• Speaker (Oral Presentation): Deliver a 25–30-minute talk to showcase original research, clinical studies, or innovative practices in digestive and gastrointestinal health.
• Speaker (Workshop): Conduct a 45–50-minute interactive workshop focused on practical tools, strategies, or therapeutic techniques in digestive healthcare.
• Speaker (Special Session): Collaborate with fellow experts in a special 45–50-minute session covering specialized areas in gastroenterology, hepatology, or related digestive sciences.
• Speaker (Symposium): Join a 45+ minute multi-presenter session, exchanging insights across related research themes and interdisciplinary topics.
• Delegate (Registration Only): Attend all sessions, gain access to resources, and enjoy full benefits of the conference experience without presenting.
• Poster Presenter: Present your research visually through poster presentations and benefit from full delegate-level access.
• Remote Presenter: Participate from anywhere in the world via virtual oral or e-poster presentation with full certification and digital access.
• Exhibitor: Promote your organization, services, or healthcare products by booking booths of various sizes in the conference exhibition area.
• Media Partner, Sponsor, or Collaborator: Collaborate with DGDC-2025 to gain brand visibility, outreach support, and strategic promotion across our global platform.

Join DGDC-2025 in Madrid, Spain on October 27-28, 2025, and be a part of shaping the future of global digestive health! Boost your visibility, publish your work, and connect with the world’s leading minds in digestive wellness and gastroenterological care.

Young Research Forum – Nurturing Future Leaders in Digestive Health:

The DGDC-2025 Young Research Forum is a dedicated platform designed to empower and showcase the innovative work of emerging scientists and clinicians in gastroenterology and digestive diseases. This forum offers a unique opportunity for young researchers to present their cutting-edge findings, engage in constructive discussions with seasoned experts, and build a robust network with peers from around the globe. It's an invaluable stepping stone for those looking to advance their careers, receive mentorship, and contribute to the future of digestive health research. We aim to foster a collaborative environment where fresh perspectives and groundbreaking ideas can flourish, leading to the next generation of discoveries.

Requirements and Eligibility:

To participate in the Young Research Forum, candidates must meet the following criteria:

• Age Limit: Be under the age of 35 years at the time of the conference (October 27, 2025).
• Academic Standing: Be a Post-Graduate student, Post-doctoral fellow, Trainee, or Junior faculty member.
• Research Focus: The submitted research topic must be original, unpublished, and directly relevant to the scientific themes of DGDC-2025 (e.g., gastroenterology, hepatology, digestive disorders, gut microbiome, diagnostic innovations, therapeutic advancements).
• Presentation: Be prepared to deliver a concise oral presentation (typically 10-15 minutes) followed by a Q&A session.
• Submission: Submit an abstract (maximum 250 words) that adheres to the conference guidelines, along with a brief CV and a letter of recommendation from a research advisor or senior faculty member.
• Language: All submissions and presentations must be in English.

Join DGDC-2025 in Madrid, Spain on October 27-28, 2025, and be a part of shaping the future of global digestive health! Boost your visibility, publish your work, and connect with the world’s leading minds in digestive wellness and gastroenterological care.

Global Market Analysis: Digestive and Gastrointestinal Diseases:

The global digestive and gastrointestinal diseases market is witnessing rapid growth driven by increasing prevalence of chronic GI disorders, rising awareness about gut health, and advancements in diagnostics and therapeutic technologies. According to industry reports, the global gastrointestinal drug market alone is projected to reach USD 65–70 billion by 2027, growing at a CAGR of 5.5% from 2022 to 2027.

Chronic conditions such as Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), colorectal cancer, liver cirrhosis, and gastroesophageal reflux disease (GERD) are among the leading health concerns worldwide, especially in North America, Europe, and rapidly in Asia-Pacific. The burden of these disorders is driving demand for effective pharmaceuticals, minimally invasive endoscopic procedures, gut microbiome-based diagnostics, and AI-integrated imaging.

Key Industry Drivers:

• Increased incidence of gastrointestinal cancers and liver disorders
• Growing demand for non-invasive diagnostic tools (e.g., capsule endoscopy, breath testing)
• Surge in gut microbiome and personalized medicine research
• Expansion of tele-gastroenterology and digital health platforms
• Rising investment in digestive health startups and biopharmaceutical research

Market Segmentation:

• By Drug Class: Antacids, laxatives, antiemetics, biologics, antidiarrheals
• By End User: Hospitals, clinics, research centers, homecare
• By Region: North America (largest), followed by Europe, APAC (fastest growing)

Growth Opportunities:

The emergence of next-generation probiotics, fecal microbiota transplantation (FMT), AI-based GI imaging, and gut-brain axis therapeutics are creating new frontiers in digestive disease research and treatment. Countries like the United States, Germany, Japan, and India are at the forefront of this innovation wave.

Why This Matters:

This market momentum underscores the importance of global forums like the 7th International Conference on Digestive and Gastrointestinal Diseases, providing a premier platform for clinicians, researchers, and industry experts to exchange ideas, showcase innovations, and foster partnerships in this evolving field.